Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Becker Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Becker Muscular Dystrophy (Genetic Disorders) pipeline landscape. Becker muscular dystrophy (BMD) is one of type of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles. ... Read More
-
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035
... Craig Mello for the discovery of RNA interference (RNAi). Subsequently, upon the approval of the first RNAi therapeutic, ONPATTRO®, in 2018, the field has witnessed a further surge in activity. Since then, three more RNAi ... Read More
-
Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End-use, And Segment Forecasts, 2022 - 2030
... period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand. Increasing concern regarding ... Read More
-
Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the ... Read More
-
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
... of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phases pushing through to FDA approval. Frost & ... Read More
-
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Cartilage Repair pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Hydrocephalus Shunts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Hydrocephalus shunts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Neuroimmunology Drug Development - Thematic Research
... nervous system health and disease. GlobalData defines a neuroimmunology drug as an agent that aims to regulate immune system activity to treat neurological diseases with underlying immune pathologies. Various neuroimmunology therapeutic strategies are being studied ... Read More
-
2022 Global Forecast for Metabolomics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments value) ... Read More
-
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 182 million diagnosed prevalent cases of dysphagia across 16 pharmaceutical markets. There is no US FDA approved marketed product for the treatment of dysphagia. R&D activity in dysphagia is minimal, ... Read More
-
Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... expected to reach USD 5,656.58 million by 2027, registering a CAGR of 7.43% from 2022 to 2027. The outbreak of COVID-19 significantly reduced hospital and healthcare services, impacting the pancreatic cancer therapeutics and diagnostics market. ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 291 million prevalent cases of anxiety across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of anxiety, Viatris is a key player in the disease space. ... Read More
-
How AI and ML Are Fueling Drug Discovery: Taking Compute and Storage to the Next Level
... drug discovery. It dwells upon some of the infrastructural challenges and complexities (including compute and storage) that the industry has been facing, provides an insight into the burgeoning and diverse market landscape of players both ... Read More
-
Alzheimer’s Therapeutics Market
... a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained ... Read More
-
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 36 million prevalent cases of lopecia areata across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Alopecia areata; however, there are several treatments used off-label to ... Read More
-
Metabolomics Services Market, 2022-2035
... 30% of the known genetic disorders are associated with small-molecule metabolism. Therefore, metabolome profiling can assist in obtaining a better understanding of the disease. The approach has also demonstrated to be capable of identifying new ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 158,442 diagnosed prevalent cases of pancreatic cancer across 16 pharmaceutical markets. There are five leading marketed drugs for the treatment of pancreatic cancer, AstraZeneca is a key player ... Read More
-
Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2029
... USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus ... Read More
-
Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030
... Discovery Market Growth & Trends The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is ... Read More
-
CRO Mass Spectroscopy Services Market Size By Service Type (Proteomics Services, Metabolomics Services), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Forecast, 2022 - 2028 The CRO mass spectroscopy services market is expected to grow significantly by 2028 on account of technological advancements in spectrometers to deliver high-resolution results. In addition, rising concerns regarding food safety ... Read More
-
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
... projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Global Cancer Supportive Care Drugs Market 2022-2028
... management of physical and psychological symptoms and side-effects across the continuum of the cancer experience from diagnosis through anticancer treatment to post-treatment care. The market for cancer supportive care drugs worldwide is expected to reach ... Read More
Research Assistance
